Nauzer (Dimenhydrinate)

Dimenhydrinate, the active ingredient in Nauzer, is a first‑generation antihistamine presented as an oral formulation for oral use. It treats motion sickness, nausea and vomiting, and vertigo in adults and children. GNH USA supplies Nauzer as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality and regulatory compliance across all markets. The company provides reliable logistics and documentation to support global distribution.

Dimenhydrinate is used to manage conditions related to the vestibular system and gastrointestinal upset. - Motion sickness: reduces nausea, vomiting, and dizziness associated with travel. - Nausea and vomiting: alleviates symptoms caused by various triggers such as chemotherapy or postoperative states. - Vertigo: helps control dizziness and imbalance due to inner‑ear disturbances.

Dimenhydrinate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Dry mouth: decreased salivation leading to thirst. - Blurred vision: temporary difficulty focusing. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm, especially in high doses. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Confusion or hallucinations: altered mental status, more common in elderly.

When considering dimenhydrinate, several safety measures should be observed. - Avoid alcohol: concurrent use may increase drowsiness. - Caution in elderly: higher risk of sedation and confusion. - Use with care in glaucoma: anticholinergic effect may worsen intra‑ocular pressure. - Monitor in patients with urinary retention: may exacerbate difficulty voiding. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture.

Dimenhydrinate can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): may increase anticholinergic toxicity. - Sedative antihistamines or CNS depressants: additive drowsiness.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs (e.g., atropine): may enhance anticholinergic side effects. - Antidepressants (tricyclics): increased risk of cardiac effects. - Alcohol: potentiates sedation and impairment.